Purchase Order 80NSSC26P0693
Award Date 5/22/26
Potential Completion Date 5/24/27
Potential Value $119K
Federal Agency
Awardee
Ultimate Awardee
Not listed NAICS Category
PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Not Competed under SAP
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
San Diego, CA 92122, USA
Solicitation Procedures
Simplified Acquisition
Number Of Offers Received
1
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The National Aeronautics and Space Administration (NASA) Shared Services Center awarded a $222,744.65 firm fixed price purchase order to Illumina, Inc., a manufacturer of sequencing and array-based solutions for genetic and genomic analysis. The contract is for the delivery of an ILLUMINA NEXTSEQ 1000 SEQUENCER SYSTEM, to be performed in San Diego, CA by June 29, 2022. Illumina has a history of providing sequencing instruments, reagents, and services to support genomic research and analysis...
- This is a firm fixed price delivery order awarded to Illumina, Inc. under a Blanket Purchase Agreement (BPA) with the federal agency identified. The award is for the provision of a MiSeq System with software, training, and a 12-month warranty, valued at $100,980.00. The contract has a period of performance through September 30, 2024 and does not utilize any set-aside provisions. Illumina is a manufacturer of genomic sequencing instruments and reagents that has previously provided similar...
- <p>The National Institute of Standards and Technology awarded a purchase order to Illumina, Inc. for a MiSeq i100 Plus System on September 12, 2025, with a ceiling value of $90,997.20. Performance is in China, with a completion date of December 12, 2025.</p>
- On March 4, 2026, the Southeast Area civilian agency awarded a delivery order valued at $108,830.08 to Illumina, Inc. for a MiSeq i100 Plus System and MiSeq i100 Plus Silver Support Plan. This firm fixed-price delivery order, with an ultimate completion date of March 3, 2027, procures advanced DNA sequencing instrumentation and associated maintenance support services. The MiSeq i100 Plus represents Illumina's mid-throughput sequencing platform, widely utilized across federal research and...
- The NIH Clinical Center awarded a purchase order valued at $256,576.92 to Illumina, Inc. for two MiSeq Sequencing Systems (serial numbers M07700 and M08636) on December 12, 2024. This firm fixed-price contract carries an ultimate completion date of December 11, 2029 and utilizes no set-aside designation. Illumina, a leading biotechnology company headquartered in San Diego, California, specializes in genetic sequencing and genomic analysis technologies. The MiSeq platform represents a...
- This firm fixed-price purchase order was awarded by the National Institutes of Health (NIH) Clinical Center to Illumina, Inc., a for-profit manufacturer of genomic sequencing instruments and reagents, to provide a MiSeq Next Generation Sequencing system. The MiSeq system will be used by the NIH Clinical Center's Department of Transfusion Medicine/Human Leukocyte Antigen (HLA) Laboratory to perform high-resolution HLA typing in support of organ transplant protocols. The contract has a ceiling...
- This is a firm-fixed-price purchase order awarded by the Naval Medical Research Command to Illumina, Inc., a for-profit manufacturer of genomic sequencing technologies. The requirement is for a MiSeq i100 Plus System, a specialized DNA/RNA sequencing instrument. The $90,997.20 contract has an ultimate completion date of July 30, 2025. Illumina is a prime contractor providing a range of genomic sequencing platforms, reagents, consumables, and maintenance services to multiple federal civilian...
- The National Aeronautics and Space Administration (NASA) Shared Services Center awarded a $202,492.50 firm fixed-price purchase order to Illumina, Inc. for the Illumina NextSeq 1000 sequencing system. This sole-source contract was awarded under the authority of Federal Acquisition Regulation (FAR) 13.106-1(b)(1)(i) since Illumina is the sole provider of the NextSeq 1000 system. The contract has no set-aside designation and will support operations at the NASA Ames Research Center. Illumina is a...
- This firm fixed price purchase order was awarded by the Department of Agriculture's Agricultural Research Service to Illumina, Inc., a manufacturer of genomic sequencing instruments and related products. The contract is for the procurement of an Illumina MiSeq DNA sequencer, with a potential value of $100,980.00. The award does not utilize any set-aside provisions and is intended to support genomic research and analysis work conducted by the agency. Illumina has a history of providing sequencing...
- The Department of Health and Human Services' Food and Drug Administration awarded a firm fixed-price purchase order to Illumina, Inc., a manufacturer of sequencing and array-based solutions, to provide a MiSeq System for $95,931.00. The MiSeq System is an integrated system for automated generation of DNA clonal clusters, sequencing, and primary and secondary analysis. The award was made on February 28, 2020 with a completion date of March 12, 2021. There was no set-aside used for this...